Tianda Pharmaceuticals Limited Announces 2026 Annual General Meeting and Closure of Register of Members

Key Highlights

• Date of AGM: The Annual General Meeting (AGM) will be held on Friday, 12 June 2026, at 10:30 a.m.
• Location: Suites 2405-2410, 24th Floor, CITIC Tower, No. 1 Tim Mei Avenue, Central, Hong Kong
• Register Closure: The register of members will be closed from Tuesday, 9 June 2026 to Friday, 12 June 2026 (both days inclusive).
• Record Date: The record date for shareholders’ entitlement to attend, speak, and vote at the AGM is 9 June 2026.
• Share Transfer Deadline: All transfer forms, along with relevant share certificates, must be lodged with Tricor Investor Services Limited (17/F, Far East Finance Centre, 16 Harcourt Road, Hong Kong) no later than 4:30 p.m. on Monday, 8 June 2026.
• Board Composition: Executive Directors: Mr. FANG Wen Quan (Chairman and Managing Director), Mr. LUI Man Sang. Non-executive Directors: Mr. ZHONG Tao, Mr. ZHU Haomiao. Independent Non-executive Directors: Mr. LAM Yat Fai, Mr. CHIU Sung Hong, Dr. XIAN Yanfang.

Details Investors Must Know

Investors and shareholders should take note of the following important points:

• Shareholder Rights: Only shareholders registered as of the record date (9 June 2026) will be entitled to attend, speak, and vote at the AGM. This is critical for those who wish to exercise their voting rights or participate in any potential corporate actions discussed during the AGM.
• Transfer Deadline: Shareholders wishing to transfer shares before the AGM must ensure all documentation is submitted to the registrar by 8 June 2026, 4:30 p.m., as no transfers will be processed during the closure period.
• Potential Price Sensitivity: While this announcement is procedural, the AGM is a forum where significant company decisions may be approved, including dividends, director appointments, or major resolutions. Investors should monitor forthcoming AGM agenda and resolutions, as these could be price-sensitive upon announcement or voting outcomes.

Implications for Share Price

The closure of the register is a standard practice, but the AGM itself is an event that could impact share price, depending on the resolutions discussed and passed. Investors should stay alert for the AGM Notice, which will detail the agenda, as critical decisions regarding company strategy, dividend payments, or board changes may be made. Such outcomes typically have a direct impact on share value.

Board and Leadership Update

The announcement confirms the current board composition, including the Chairman and Managing Director Mr. FANG Wen Quan, and lists both executive and independent directors. The stability and expertise of the board may be viewed positively, but investors should await further AGM documentation to assess if any board changes or strategic shifts are proposed.

Action Points for Investors

• Ensure shares are registered by the deadline if planning to participate in the AGM.
• Watch for further announcements detailing the AGM agenda, as these will be critical for investment decisions.
• Monitor for any resolutions or proposals that may impact dividend policy, corporate governance, or future direction of Tianda Pharmaceuticals Limited.

Conclusion

The announcement sets procedural steps for shareholder participation but signals the upcoming AGM as a potentially important event for the company. While no explicit price-sensitive information has been disclosed yet, investors should stay vigilant for further announcements relating to the AGM agenda and resolutions, as these could materially affect share value.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own research and consult professional advisors before making any investment decisions. The author assumes no responsibility for any outcomes based on the information provided.

View TIANDA PHARMA Historical chart here